Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AltruBio Announces FDA Clearance of IND Application for
AltruBio Inc. on LinkedIn: We have launched our Twitter page! Follow us ...
AltruBio Inc. | LinkedIn
AltruBio Announces Formation of Scientific Advisory Board | The Manila ...
Nadia Ho on LinkedIn: AltruBio has been nominated as a finalist in the ...
AltruBio Inc. on LinkedIn: #ash2022 #immunological
Immune checkpoint enhancer biotech AltruBio raises $225m | pharmaphorum
#i | AltruBio Inc. | 12 comments
AltruBio Inc. on LinkedIn: Join us on December 15th at 12:00pm ET for ...
AltruBio presents new data on ALTB-268 for UC at FOCIS | AltruBio Inc ...
#ulcerative | AltruBio Inc.
#pantheon2024 | AltruBio Inc.
AltruBio's novel approach to autoimmune disease | AltruBio Inc. posted ...
AltruBio at Leerink Global Healthcare Conference | AltruBio Inc. posted ...
AltruBio Forms Clinical Advisory Board for IBD Treatment | AltruBio Inc ...
AltruBio to Present at Biotech Showcase Digital 2021 - BioSpace
AltruBio
AltruBio Inc. on LinkedIn: #altrubioculture
MTS Health Partners on LinkedIn: AltruBio Secures up to $225M ...
AltruBio on Twitter: "At this year’s @DDWMeeting, Dr. David Rubin ...
Our President and CEO, Dr. Judy Chou and the entire AltruBio Leadership ...
AltruBio declares FDA approval on IND submission for ALTB-268, an ...
AltruBio raises $225 million to develop ulcerative colitis drug | STAT
AltruBio raises $225 million to develop ulcerative colitis drug ...
AltruBio Inc. on LinkedIn: Today, we announced the completion of ...
2022 AltruBio Laboratory - YouTube
AltruBio Presents New Preclinical Data at FOCIS 2025 Demonstrating ALTB ...
#altrubio #immunology | AltruBio Inc.
AltruBio lands up to $225M after shift to immune drug research ...
#apecceosummit2024 #apec #apecperu2024 | AltruBio Inc.
We're proud to announce that Dr. | AltruBio Inc.
AltruBio Inc. on LinkedIn: Developing Novel Treatments for ...
AltruBio $225M Series B Funding (2024) | Investors & Contacts | Fundup AI
Edwin Powers on LinkedIn: Always a pleasure representing AltruBio Inc ...
#icymi | AltruBio Inc.
ALTRUBIO - AltruBio Inc. Trademark Registration
📌 AltruBio Inc.'s Dr. Judy Chou will present at Festival of Biologics ...
AltruBio Secures Series B Funding for Autoimmune Regulator — The Pharma ...
#collaborations #partnerships #jpm2026 #innovation #judychou | AltruBio ...
AltruBio Commences Initial Participant Recruitment for Second-Phase ...
BIO 2026: AltruBio believes that its PSGL-1, a T-cell checkpoint ...
In 2024, AltruBio Inc. not only survived but thrived, achieving two ...
New name, new board, new focus: AltruBio relaunches with $63M series A ...
Dr. Ping-Yang (Ping) Yeh, Ph.D., the president of AltruBio Taiwan ...
AltruBio Inc. on LinkedIn: #inflammatoryboweldisease #ibd
Dr Chou to Speak at American Biomanufacturing Summit | AltruBio Inc ...
#ddw2024 | AltruBio Inc.
AltruBio Secures Up To $225M Series B | citybiz
从肿瘤换道自免疾病后,这家初创公司融了4亿-36氪
2022新一代生物新锐榜单出炉,30家公司入选 - 知乎
郭台銘、尹衍樑為何都投資全心醫藥?「三個台灣第一」募資逾72億|天下雜誌
Excited to share the completion of our Series B financing round funded ...
#biotech #leadership #startups #healthcareinnovation #autoimmunedisease ...
Pharma News | AstraZeneca, Biogen, AltruBio, GSK
Dr. Judy Chou (@biologicsiscool) / Posts / X
Recently, our leadership team had the great pleasure of visiting the ...
ALTB-168
ALTB-168 has demonstrated signs of clinical efficacy in Psoriasis ...
Our President & CEO, Dr. Judy Chou recently had the privilege to be ...
Join
The San Francisco Business Times just released the list of “The most ...
ALTB-268 for Ulcerative Colitis Clinical Trial 2024 | Power
To celebrate the close of our Series B and our first in-person ...
Dr. Judy Chou on LinkedIn: Welcome Gene W. Lee, PhD, our new Vice ...
Thank you to the New York Stock Exchange NYSE for celebrating our ...
We’re thrilled to welcome Adrian Serone, PhD, AltruBio’s new Vice ...
Patients
Simona Reed (@1SimonaReed) / Posts / X
Our President and CEO, Dr. Judy Chou is featured by New York Stock ...
Dr. Judy Chou will attend the HSBC Global Investment Summit on March 25 ...
Publications
You are invited to join the upcoming Fierce Biotech virtual webinar in ...
R&D Update on AltruBio’s Immune Checkpoint Enhancer Platform for ...
#thebiohub #podcast #biotech #leadership #judychou #altrubio # ...
Our President & CEO, Dr. Judy Chou will be presenting at the RBC ...
Our President and Chief Executive Officer, Dr. Judy Chou is invited to ...
Making the Transition from Academia to CEO
Edwin Powers on LinkedIn: Making progress with our 1st UC patient dosed ...
#bious25 #biomanufacturing #digitaltransformation #biomanufacturing # ...
Chih-Huang Lin on LinkedIn: #altrubio
Close
Chutes & Ladders—AltruBio snags new CMO with resume at Sublimity, Ardea ...
#immunecheckpointenhancer #immunology | Dr. Judy Chou
自免TOP5 | 全球融资额最高的自免Biotech - 知乎
We're proud to see our President and CEO, Dr. Judy Chou, featured in ...
#innovationinbiologics #followyourpassion #leadership | Philip Ho
CGTI 2027 · Cell and Gene Therapy Innovation · Berlin
#cccongress2025 #uc #ulcerativecolitis #ibd #ibdtherapies # ...
alberto rubio (@altrubio) / Posts / X
(Leiolizumab (AltruBio))-药物靶点:PSGL-1_在研适应症:溃疡性结肠炎,自身免疫性疾病,器官移植排斥_专利_临床_研发
潰瘍性結腸炎(Ulcerative colitis)治療突破:AltruBio籌集2.25億美元發展新藥,強生(J&J)Tremfya三期臨床 ...
Building better biologics: Overcoming hurdles in protein therapy ...
#altrubio #bioequityeurope #partnership | Dr. Judy Chou
全心醫藥生技股份有限公司-環球生技月刊
Clinical Research Jobs | BioSpace